Nanophase Reports Third Quarter 2013 Financial Results

ROMEOVILLE, Ill., Oct. 30, 2013 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for the third quarter and nine month periods ended September 30, 2013.

Nanophase CEO and President Jess Jankowski commented, "We continue to run ahead of last year, and expect 2013FY revenues to be similar to 2012's. Our primary focus remains the rollout of our new initiatives, as success in a single new application offers dramatic and positive movement in our competitive position. We are not a company looking to grow at 10 percent annually. We are taking big swings."

Third Quarter 2013 Financial Highlights

  • Revenue for the third quarter was $2.2 million, vs. the $2.1 million reported during the third quarter of 2012.
  • The net loss for the quarter was $0.6 million, or a loss of $0.02 per share, compared to a net loss of $0.7 million, or $0.02 per share, for the comparable 2012 quarter.
  • The Company finished the quarter with approximately $3.3 million in cash and cash equivalents; the company has no debt.

Nine months ended September 30, 2013 Financial Highlights

  • Revenue for the first nine months of 2013 was $7.8 million, up $0.5 million when compared to $7.3 million in the first nine months of 2012.
  • The net loss for the nine month period ended September 30, 2013 was $1.6 million, or a loss of $0.06 per share, compared to a net loss of $1.8 million, or $0.08 per share, for the comparable 2012 period.

Jankowski continued, "The markets in both the battery and energy control areas that we are targeting are very well developed and defined. We believe we have a strong value proposition in each, and each fits nicely in our core competency. Continuing to develop a handful of new initiatives on top of continuous improvement in the existing business should put us where we want to be."

Shareholders and members of the financial community are encouraged to participate in the upcoming conference call, where Mr. Jankowski will discuss the company's current and long-term prospects.

Third Quarter 2013 Conference Call

The Nanophase conference call, to be hosted by Jess Jankowski, the Company's President & CEO, is scheduled for October 31, 2013, at 10:00 a.m. CDT, 11:00 a.m. EDT. The conference call dial-in number for U.S. callers is 877-312-8776 and for international callers is 408-774-4007. The conference ID is 55076665. Please dial in to the conference at least five minutes before the call is scheduled to begin.

The call may also be accessed through the company's website, at www.nanophase.com, by clicking on the link under News Center and Calendar of Events to listen to a webcast of the event.

Use of Non-GAAP Financial Information

Nanophase believes that the presentation of results excluding certain items, such as non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles.

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.

Forward-Looking Statements

This press release contains words such as "expects," "shall," "will," "believes," and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company's dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company's nanocrystalline materials; the Company's manufacturing capacity and product mix flexibility in light of customer demand; the Company's limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company's dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company's Form 10-K filed March 29, 2013. In addition, the Company's forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

NANOPHASE TECHNOLOGIES CORPORATION
BALANCE SHEETS
September 30, 2013 December 31,
ASSETS (Unaudited) 2012
Current assets:
Cash and cash equivalents $ 3,307,104 $ 4,124,234
Investments 30,000 30,000
Trade accounts receivable, less allowance for doubtful accounts of $6,000 on September 30, 2013 and December 31, 2012 988,304 1,031,405
Other receivable 844 27,167
Inventories, net 990,756 1,138,482
Prepaid expenses and other current assets 226,894 240,870
Total current assets 5,543,902 6,592,158
Equipment and leasehold improvements, net 2,629,851 3,027,671
Other assets, net 27,971 29,829
$ 8,201,724 $ 9,649,658
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of capital lease obligations 30,052 34,526
Accounts payable 583,424 680,452
Accrued expenses 553,685 484,460
Total current liabilities 1,167,161 1,199,438
Long-term portion of capital lease obligations 18,397 62,755
Long-term deferred rent 633,646 636,628
Asset retirement obligation 158,424 153,967
Total long-term liabilities 810,467 853,350
Stockholders' equity:
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding -- --
Common stock, $.01 par value, 35,000,000 shares authorized; 28,468,162 and 28,458,162 shares issued and outstanding on September 30, 2013 and December 31, 2012, respectively 284,682 284,582
Additional paid-in capital 95,707,861 95,512,065
Accumulated deficit (89,768,447) (88,199,777)
Total stockholders' equity 6,224,096 7,596,870
$ 8,201,724 $ 9,649,658
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended Nine months ended
September 30, September 30,
2013 2012 2013 2012
Revenue:
Product revenue, net $ 2,156,844 $ 2,028,529 $ 7,810,058 $ 7,061,504
Other revenue 7,106 72,435 16,356 231,591
Net revenue 2,163,950 2,100,964 7,826,414 7,293,095
Operating expense:
Cost of revenue 1,648,417 1,571,575 5,555,601 5,349,594
Gross profit 515,533 529,389 2,270,813 1,943,501
Research and development expense 375,442 396,503 1,257,263 1,210,168
Selling, general and administrative expense 772,644 789,169 2,590,596 2,546,334
Loss from operations (632,553) (656,283) (1,577,046) (1,813,001)
Interest income 379 -- 1,123 --
Interest expense (1,623) (2,056) (10,748) (5,093)
Other, net 901 -- 18,001 7,199
Loss before provision for income taxes (632,896) (658,339) (1,568,670) (1,810,895)
Provision for income taxes -- -- -- --
Net loss $ (632,896) $ (658,339) $ (1,568,670) $ (1,810,895)
Net loss per share - basic and diluted $ (0.02) $ (0.02) $ (0.06) $ (0.08)
Weighted average number of basic and diluted common shares outstanding 28,468,162 26,960,880 28,467,686 23,139,731
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS - EXPANDED SCHEDULE
(Unaudited)
Three months ended Nine months ended
September 30, September 30,
2013 2012 2013 2012
Revenue:
Product revenue, net $ 2,156,844 $ 2,028,529 $ 7,810,058 $ 7,061,504
Other revenue 7,106 72,435 16,356 231,591
Net revenue 2,163,950 2,100,964 7,826,414 7,293,095
Operating expense:
Cost of revenue detail:
Depreciation 180,662 186,661 540,295 585,055
Non-Cash equity compensation 5,648 7,166 20,848 24,549
Other costs of revenue 1,462,107 1,377,748 4,994,458 4,739,990
Cost of revenue 1,648,417 1,571,575 5,555,601 5,349,594
Gross profit 515,533 529,389 2,270,813 1,943,501
Research and development expense detail:
Depreciation 28,604 35,684 93,185 102,034
Non-Cash equity compensation 15,740 18,628 57,910 63,167
Other research and development expense 331,098 342,191 1,106,168 1,044,967
Research and development expense 375,442 396,503 1,257,263 1,210,168
Selling, general and administrative expense detail:
Depreciation and amortization 13,758 21,518 40,602 62,577
Non-Cash equity compensation 21,813 36,881 113,418 134,957
Other selling, general and administrative expense 737,073 730,770 2,436,576 2,348,800
Selling, general and administrative expense 772,644 789,169 2,590,596 2,546,334
Loss from operations (632,553) (656,283) (1,577,046) (1,813,001)
Interest income 379 -- 1,123 --
Interest expense (1,623) (2,056) (10,748) (5,093)
Other, net 901 -- 18,001 7,199
Loss before provision for income taxes (632,896) (658,339) (1,568,670) (1,810,895)
Provision for income taxes -- -- -- --
Net loss $ (632,896) $ (658,339) $ (1,568,670) $ (1,810,895)
Non-GAAP Disclosure (see note regarding Non-GAAP disclosures):
Addback Interest, net 1,244 2,056 9,625 5,093
Addback Depreciation/Amortization 223,024 243,863 674,082 749,666
Addback Non-Cash Equity Compensation 43,201 62,675 192,176 222,673
Adjusted EBITDA $ (365,427) $ (349,745) $ (692,787) $ (833,463)

CONTACT: COMPANY CONTACT Nancy Baldwin Investor Relations 630-771-6708Source:Nanophase Technologies Corporation